03/18/2025
4:28 PM | Allogene Therapeutics (Issuer)
Beneski Benjamin Machinas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:30 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
9:01 AM | Allogene Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
03/05/2025
3:11 PM | Allogene Therapeutics (Issuer)
Beneski Benjamin Machinas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
8:58 PM | Allogene Therapeutics (Issuer)
Beneski Benjamin Machinas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2025
8:02 AM | Allogene Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SCHEDULE 13G | |
02/05/2025
3:16 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:32 PM | Allogene Therapeutics (Subject)
Roberts Zachary (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
3:28 PM | Allogene Therapeutics (Subject)
Parker Geoffrey M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
7:35 AM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2025
7:10 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ALLO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Allogene Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/28/2025
7:11 PM | Allogene Therapeutics (Issuer)
Belldegrun Arie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:13 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:14 PM | Allogene Therapeutics (Issuer)
Yoshiyama Annie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:15 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:16 PM | Allogene Therapeutics (Issuer)
Douglas Earl Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:30 PM | Allogene Therapeutics (Issuer)
Roberts Zachary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:22 PM | Allogene Therapeutics (Subject)
Roberts Zachary (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
3:53 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
1:15 PM | Allogene Therapeutics (Subject)
Humer Franz B (Reporting)
| Form 144/A | |
12/02/2024
1:11 PM | Allogene Therapeutics (Subject)
Humer Franz B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
9:57 AM | Allogene Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/23/2024
3:21 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
2:24 PM | Allogene Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G/A | |
06/20/2024
3:31 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:33 PM | Allogene Therapeutics (Subject)
MESSEMER DEBORAH M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:30 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:28 PM | Allogene Therapeutics (Issuer)
Kazam Joshua A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:29 PM | Allogene Therapeutics (Issuer)
WITTE OWEN N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:30 PM | Allogene Therapeutics (Issuer)
Humer Franz B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:33 PM | Allogene Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:34 PM | Allogene Therapeutics (Issuer)
Barrett Elizabeth A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:35 PM | Allogene Therapeutics (Issuer)
Mayo Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:25 PM | Allogene Therapeutics (Issuer)
MESSEMER DEBORAH M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:09 PM | Allogene Therapeutics (Issuer)
Humer Franz B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
1:08 PM | Allogene Therapeutics (Subject)
Humer Franz B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
8:33 PM | Allogene Therapeutics (Issuer)
Belldegrun Arie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:01 PM | Allogene Therapeutics (Issuer)
Chang David D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:02 PM | Allogene Therapeutics (Issuer)
Parker Geoffrey M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:38 PM | Allogene Therapeutics (Filer)
| Form 424B5 | |
05/14/2024
3:40 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Trump’s Final Plan (Ad) Presidential insider exposes shocking plot to reshape U.S. economy:
The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed. Click here for the full story. |
05/13/2024
3:02 PM | Allogene Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
11:15 PM | Allogene Therapeutics (Filer)
| Form EFFECT | |
04/24/2024
3:18 PM | Allogene Therapeutics (Issuer)
MOORE TIMOTHY L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:31 PM | Allogene Therapeutics (Filer)
| Form DEF 14A | |
04/23/2024
3:32 PM | Allogene Therapeutics (Filer)
| Form DEFA14A | |
04/23/2024
3:33 PM | Allogene Therapeutics (Filer)
| Form ARS | |
04/22/2024
3:09 PM | Allogene Therapeutics (Subject)
MOORE TIMOTHY L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
